A close partnership between haematology and renal teams achieves best possible outcomes

Approximately 20% of newly diagnosed myeloma patients have significant renal impairment at the time of their diagnosis, and about 10% of these immediately require dialysis. The renal complications of myeloma are amongst the most important in terms of their potential to affect patients’ quality of life. This is particularly true for patients who need dialysis…

Improving patient experience with pharmacy-led clinics

Pharmacy teams are important members of the multi-disciplinary teams responsible for the treatment and care of myeloma patients but are not always part of clinics. Chesterfield Royal Hospital has found that integrating a pharmacist into their weekly myeloma clinics has led to improvements in the clinical service and patient satisfaction. Rebecca Clark, Principal Haematology-Oncology Pharmacist…